• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Rater Station®

Psychiatry and neurology among other therapeutic areas rely on subjective clinician-reported outcome measures that require specialized solutions to ensure endpoint reliability and optimize signal detection potential​

DOWNLOAD BROCHURE
website - image ecr 2

Control endpoint measure risk factors​

Trust Signant to drive the highest quality evidence generation and successful clinical endpoint signal detection with our leading Rater Station solution. Combined with built-in scientific expertise, our technology is designed to solve the unique challenges of complex clinician-reported outcome measures.​

Reduce scale administration errors

Pre-set workflows, on-screen guidance, and automated scoring validation ensure that scales are administered and scored correctly

Improve data reliability

Prevent missing or incomplete data and transcription errors; build regulatory-compliant audit trails

Optimize subjective assessments​

Reduce inter- and intra-rater variability with integrated quality monitoring, and capture audio/video interviews for expert central review/ratings​

Why choose Rater Station?​

Signant’s Rater Station solution integrates deep clinical expertise with specialized technology to overcome the unique challenges of complex clinician-reported outcomes. Purpose-built by renowned expert raters and refined through two decades of real-world implementation, our solution optimizes signal detection by ensuring highest quality ClinRO evidence generation.​

Automated Scoring

Automated scoring validation when applicable

On-Screen Guidance

On-screen guidance and alerts, helping raters to correctly administer scales

Edit Checks

Flexible and customizable edit checks and notifications

Audio/Video Capture

Integrated and secure audio/video capture of interviews that can be reviewed by independent expert clinicians

Deployment Flexibility

Deployment options supporting web-based or offline access to meet diverse study requirements and site capabilities​

Rater Reviews

Periodic rater reviews for quality control

Intuitive Charts

Analytics highlighting outlying data patterns color-coded graphs and intuitive charts

Audit Trail

An audit trail that captures data modifications made prior to submission

Electronic vs paper

Clinician-reported outcomes (ClinROs) that use paper make studies susceptible to human error and missing data. Our Electronic Clinician Ratings solution improves data quality and endpoint reliability through intelligent features that proactively detect scoring and administrative errors prior to submission, reducing errors by up to 80% compared to paper and form-based eCOA​.

DOWNLOAD BROCHURE

The specialist partner for your complex ClinRO trials​

Trust Signant to ensure your enrolled patients meet eligibility requirements, and raters provide consistent and accurate assessments with minimal variability to drive high quality assessments and scoring throughout your study​

Dawie Wessels

Dawie’s deep expertise across multiple therapeutic areas, multinational development leadership, and experience in associated commercial growth supports the expanding impact of the Signant Science and Medical team. Dawie joins us from AES, where he served as Chief Medical Officer for five and a half years. Prior to AES, he held various research and senior leadership roles at Parexel for over 15 years, developing and implementing medical scientific focused business strategies across the early phase space. Dawie holds MBA and MBChB MBA (Medicine and Business) degrees from University of the Free State, South Africa. We are rightly proud of our science and medical heritage and how it has contributed to – and continues to – position us as leaders in our industry. Building on the therapeutic approach to our sales pipeline, the development of our offerings across as many therapeutic areas as possible continues under Dawie’s leadership. Originally hailing from South Africa, Dawie is based in the UK.

Dawie Wessels

Dawie’s deep expertise across multiple therapeutic areas, multinational development leadership, and experience in associated commercial growth supports the expanding impact of the Signant Science and Medical team. Dawie joins us from AES, where he served as Chief Medical Officer for five and a half years. Prior to AES, he held various research and senior leadership roles at Parexel for over 15 years, developing and implementing medical scientific focused business strategies across the early phase space. Dawie holds MBA and MBChB MBA (Medicine and Business) degrees from University of the Free State, South Africa. We are rightly proud of our science and medical heritage and how it has contributed to – and continues to – position us as leaders in our industry. Building on the therapeutic approach to our sales pipeline, the development of our offerings across as many therapeutic areas as possible continues under Dawie’s leadership. Originally hailing from South Africa, Dawie is based in the UK.

Ed Pollack

Ed Pollack serves as Chief Technology Officer where he steers strategy and oversees delivery of the products and systems underpinning Signant’s growth strategy. He is responsible for driving high-performance, cross-functional teams across several disciplines and leading the development and optimization of clinical trial solutions for Signant’s life sciences customers across the globe. 

Ed joins Signant from Elsevier, a leader in helping healthcare professionals advance science and improve patient outcomes, where he served as vice president of technology. His experience there, as well as his extensive background in software engineering, ensure Signant is prepared with the leadership and vision to continue scaling through accelerated growth while delivering industry-leading solutions to customers.  

Prior to Elsevier, Ed held technology leadership roles at several companies focused on supporting the regulatory business process of global life sciences companies. 

Ed holds a Bachelor of Business Administration in Computer Science from Temple University. 

EM-2025-01-Getting-Started-With-eCOA-Icon-2
Comprehensive Technology

Purpose-built for complex clinician-reported outcome measures, our proprietary technology offers advanced electronic clinician rating capabilities with flexible deployment options​

Biologics-Icon-Guidance
Endpoint Reliability

Our internal clinicians and global network of independent central reviewers and raters are trained, qualified, and regularly calibrated to drive the highest levels of endpoint reliability and standardized assessment quality​

EM-2025-01-Getting-Started-With-eCOA-Icon-5
Scientific Consulting

Protocol and scale consultations help you navigate the complexities of electronic clinician ratings, including obtaining licenses and validating translations​

Biologics-Icon-QualityData
Actionable Analytics

Clinically-driven proprietary algorithms and in-depth analysis and interpretation to identify data quality risks, providing early detection and proactive remediation to protect endpoint reliability and optimize signal detection​

Explore associated solutions and services

website - icons - 2

Rater Training & Qualification

A proven approach to ensure scoring consistency & endpoint quality

EXPLORE FEATURES
icon representing statistical analysis

PureSignal Analytics

Proactively detect and mitigate endpoint data quality risks to safeguard your signal detection ​

EXPLORE FEATURES
website - icons scale

Scale & License Management

Simplify selecting and using appropriate clinical outcome assessments for studies

EXPLORE FEATURES
website - icons central rating

Central Rating & Consulting

Identify and act on data trends with collaborative action planning

EXPLORE FEATURES

FAQs

What is an endpoint in clinical research?

Clinical endpoints are measurable outcomes used to address the objectives of a clinical trial, such as survival, decreased pain, or the absence of disease.

What is a primary endpoint in clinical trial?

Primary endpoints measure outcomes that will answer the most important question being asked by a trial, such as whether a new treatment is better at preventing disease-related death than the standard therapy. Secondary endpoints answer other relevant questions about the same study, such as patient-reported outcomes on their quality of life.

How do you ensure data quality in clinical research?

Innovative technology, routine training, and guidance from experienced subject matter experts help researchers ensure high data quality. Signant offers all of those solutions and services, catering to the unique needs of sponsors and regulators.

Want to learn more?

Deploy Rater Station to your study to collect reliable clinician-rated endpoint data – contact our team today

DISCUSS PROTOCOL